
Researchers are actively investigating how probiotics influence numerous aspects of human health.

Researchers are actively investigating how probiotics influence numerous aspects of human health.

A recently published study found that a synergistic blend of bilberry, standardized to 36% anthocyanins, astaxanthin, and lutein helped reduce eye fatigue after screen time.

Phenolaeis has developed a prototype called First Date: Date and Oat Bites, a clean label chewy granola product with four premium functional ingredients to support mood and energy.

Why Pharmavite believes mental health and OTC alternatives are two of the biggest opportunities moving forward for health, wellness, and supplements

Cognitive health concerns people of all ages, giving dietary supplement manufacturers numerous avenues for reaching customers.

Increased stress and tiredness, especially over the past year, are sending consumers to supplement and food shelves to find support.

Convenience and science are paving the way for new health products for gamers.

The cognitive health space is now for everyone, offering multiple benefits that encompass the needs of different demographics.

Kaneka Probiotics added a new probiotic strain to its portfolio: Lactobacillus plantarum DR7.

We asked science-centered experts to share their picks for the most exciting sleep ingredients on their radars. Here’s what they told us.

A recent animal study found a potential neuroprotective effect from a turmeric extract (BCM-95 from Arjuna Natural Pvt. Ltd.) in combination with turmeric essential oil (Curcugreen from Arjuna). Neurotoxicity was induced by injecting aluminum chloride, which impairs spatial learning and memory.

According to Maypro, the ingredient has been the subject of eight human clinical studies demonstrating its ability to help reduce markets of cognitive decline, preserve cognitive function, aid brain blood flow, reduce neuro-inflammation, enhance memory, and reduce loss of memory.

Paused for pandemic? Reflections and predictions on COVID-19 from sports nutrition suppliers

A recently published study found that supplementation with a proprietary sage extract supported acute and long-term cognitive outcomes.

Despite a mild sales decline in 2020, probiotics remain a top-selling ingredient across channels. Hear expert predictions about how probiotics' ability to straddle multiple categories, and the growing understanding of microbiome health benefits, will continue to propel probiotics' growth in 2021.

Ashwagandha sales grew impressively in 2020, with chronic stress and sleeplessness on the rise especially during the COVID-19 pandemic. Experts discuss how ashwagandha is poised to lead the adaptogens category into the mainstream in 2021.

Mushrooms offer a number of health benefits, including immune and brain support. With continued double-digit growth in the natural retail channel, the mushroom ingredient category is poised for mainstream success.

Melatonin saw huge sales gains in 2020 during the COVID-19 pandemic from consumers seeking sleep support. What will the market look like in 2021?

Gencor has launched a new proprietary and patented botanical ingredient called Calmaluma designed to support stress. The ingredient is an extract of Caralluma Fimbriata, an edible cactus from India.

Predictions from Nutritional Outlook's esteemed Editorial Advisory Board.

Unibar Corp. partnered with Health Thru Nutrition to launch a capsanthin-based supplement using CapsiClear, a patent-pending combination of carotenoids standardized to 50 percent capsanthin, for eye health formulations.

Lipogen launched CognoLipid, a phospholipid formula combining phosphatidylserine (PS) and phosphatidic acid (PA) for the support of cognitive performance and chronic stress.

In a joint press release, AstaReal, Beneo, and Gelita are highlighting the potential of the emerging e-sports and gaming market for food and dietary supplement manufacturers.

DuPont Nutrition & Biosciences launched Howaru Calm, a probiotic aimed to support consumer’s response to stress.

The agreement is for the development of pharmaceutical therapies for brain and eye health based on Aker’s Lysoveta LPC-bound EPA and DHA.